<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04467424</url>
  </required_header>
  <id_info>
    <org_study_id>Ketofol-Lidocaine</org_study_id>
    <nct_id>NCT04467424</nct_id>
  </id_info>
  <brief_title>Recovery After Total Intravenous Anesthesia With Ketofol Versus Mixture of Ketofol and Lidocaine for Short Pediatric Surgery</brief_title>
  <acronym>Lidoketofol</acronym>
  <official_title>TIVA With Ketofol Versus Lidoketofol for Short-term Anesthesia on Pediatric Patients; Effects on Recovery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital of Split</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital of Split</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Two hundred children aged 1-12 years undergoing short surgery will be randomized into two
      groups. Ketofol will be used for induction and maintenance of anesthesia in group l. .Ketofol
      with lidocaine will be prepared for group ll. A reducted McFarlan infusion dose will be used.
      Extubating time, duration of anesthesia, length of stay in post-anesthesia care unit (PACU)
      will be recorded.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aim of the research: In this study investigators want to examine the effectiveness of the use
      of ketofol and a mixture of ketofol and lidocaine on the total consumption of opioids and on
      the postoperative recovery of pediatric patients. Investigators will evaluate the safety,
      efficacy, and outcomes of the anesthesia procedure with respect to the administration of
      different anesthetics, specific pharmakocinetic profiles and compare the length of recovery
      between patients in two groups.

      Including criteria: children aged 1 to 12 years who underwent short surgery (up to 60 min).

      Primary and secondary outcome measures: The primary outcome of this study will be extubation
      time and the secondary outcome will be time spend in PACU.

      Description of the study: Each subject included in the study will be given general anesthesia
      with ketofol or ketofol and lidocaine, with the addition of fentanyl. After 20 s the LMA will
      be placed. Maintenance of anesthesia will be performed using an air / oxygen mixture (50% /
      50%) and an infusion of ketofol or ketofol and lidocaine. Ketofol will be prepare in a ratio
      of 1: 4 for induction and 1: 7 for maintenance. The same mixtures of ketofol will be added 1
      ml of 2% lidocaine for the second group of patients. After extubation, patients will be
      transferred to the PACU.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">June 20, 2020</start_date>
  <completion_date type="Anticipated">October 2020</completion_date>
  <primary_completion_date type="Anticipated">August 20, 2020</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effect of TIVA with ketofol and ketofol plus lidocaine on extubation time in children</measure>
    <time_frame>up to 24 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of TIVA with ketofol and ketofol plus lidocaine on length of stay in the PACU</measure>
    <time_frame>up to 24 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effect of TIVA with ketofol and ketofol plus lidocaine on total opioid consumption</measure>
    <time_frame>up to 24 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Surgical Procedure, Unspecified</condition>
  <arm_group>
    <arm_group_label>Pediatric anesthesia with ketofol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ketamine, propofol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pediatric anesthesia with ketofol plus lidocaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ketamine, propofol, lidocaine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ketamine, propofol</intervention_name>
    <description>anesthesia with ketofol in pediatric surgery</description>
    <arm_group_label>Pediatric anesthesia with ketofol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ketamine, propofol, lidocaine</intervention_name>
    <description>anesthesia with ketofol plus lidocaine in pediatric surgery</description>
    <arm_group_label>Pediatric anesthesia with ketofol plus lidocaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  surgical procedures max 60 min ASA I and II

        Exclusion Criteria:

          -  ASA &gt; II surgical procedures longer than 60 min
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Hospital of Split</name>
      <address>
        <city>Split</city>
        <zip>21000</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Croatia</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>June 27, 2020</study_first_submitted>
  <study_first_submitted_qc>July 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 13, 2020</study_first_posted>
  <last_update_submitted>July 8, 2020</last_update_submitted>
  <last_update_submitted_qc>July 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital of Split</investigator_affiliation>
    <investigator_full_name>Ana N Bili≈°kov, MD</investigator_full_name>
    <investigator_title>Pediatric anesthesiologist</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Ketamine</mesh_term>
    <mesh_term>Propofol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

